Lataa...
RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis
Bone destruction occurs in aging and numerous diseases, including osteoporosis and cancer. Many cancer patients have bone osteolysis that is refractory to state-of-the-art treatments, which block osteoclast activity with bisphosphonates or by inhibiting the RANKL pathway. We previously showed that m...
Tallennettuna:
| Julkaisussa: | Sci Transl Med |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771677/ https://ncbi.nlm.nih.gov/pubmed/28123075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aai9338 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|